Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5876
PUT
Ascendis Pharma A/S
ASND
$16.2B
| $1.75M | ﹤0.01% |
12,700
-14,000
| -52% | -$1.84M |
|
5877
PUT
Fortive
FTV
$18.3B
| $1.75M | ﹤0.01% |
30,919
-14,332
| -32% | -$823K |
|
|
MPT
5878
Medical Properties Trust
MPT
$2.42B
| $1.75M | ﹤0.01% |
442,171
-700,140
| -61% | -$3.14M |
|
5879
CALL
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $1.74M | ﹤0.01% |
8,800
-2,000
| -19% | -$411K |
|
5880
iShares US Tech Breakthrough Multisector ETF
TECB
$494M
| $1.74M | ﹤0.01% |
32,785
+14,305
| +77% | +$767K |
|
5881
CALL
Beyond Meat
BYND
$200M
| $1.74M | ﹤0.01% |
15,453
-12,930
| -46% | -$2.06M |
|
5882
Nelnet
NNI
$4.5B
| $1.74M | ﹤0.01% |
+16,294
| New | +$1.8M |
|
5883
Donegal Group Class A
DGICA
$685M
| $1.74M | ﹤0.01% |
112,404
+93,627
| +499% | +$1.46M |
|
5884
PUT
Huntsman Corp
HUN
$1.81B
| $1.74M | ﹤0.01% |
96,400
-36,600
| -28% | -$762K |
|
5885
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$149M
| $1.74M | ﹤0.01% |
+74,099
| New | +$1.85M |
|
|
YMAB
5886
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.74M | ﹤0.01% |
221,914
-52,633
| -19% | -$641K |
|
5887
CALL
Danaos Corp
DAC
$2.66B
| $1.74M | ﹤0.01% |
21,700
+8,400
| +63% | +$692K |
|
5888
iShares Russell 2500 ETF
SMMD
$3.86B
| $1.74M | ﹤0.01% |
25,536
+7,173
| +39% | +$502K |
|
5889
Denison Mines
DNN
$2.89B
| $1.74M | ﹤0.01% |
964,348
-3,589,045
| -79% | -$7.55M |
|
5890
Teekay Tankers
TNK
$3.09B
| $1.74M | ﹤0.01% |
43,616
-33,620
| -44% | -$1.56M |
|
5891
PUT
ARK 21Shares Bitcoin ETF
ARKB
$2.45B
| $1.73M | ﹤0.01% |
+55,800
| New | +$1.54M |
|
5892
PUT
Advanced Drainage Systems
WMS
$11.2B
| $1.73M | ﹤0.01% |
15,000
-3,000
| -17% | -$416K |
|
5893
FlexShares STOXX Global ESG Select Index Fund
ESGG
$115M
| $1.73M | ﹤0.01% |
10,313
-41,541
| -80% | -$7.12M |
|
5894
Titan International
TWI
$427M
| $1.73M | ﹤0.01% |
255,105
+94,649
| +59% | +$682K |
|
5895
WisdomTree International Equity Fund
DWM
$692M
| $1.73M | ﹤0.01% |
32,839
+28,677
| +689% | +$1.57M |
|
5896
PUT
Beam Therapeutics
BEAM
$2.8B
| $1.73M | ﹤0.01% |
69,700
+10,600
| +18% | +$271K |
|
|
LOMA
5897
Loma Negra
LOMA
$1.09B
| $1.73M | ﹤0.01% |
144,652
+134,143
| +1,276% | +$1.39M |
|
5898
CALL
Global X S&P 500 Covered Call ETF
XYLD
$3.29B
| $1.73M | ﹤0.01% |
41,200
+11,700
| +40% | +$491K |
|
5899
Krystal Biotech
KRYS
$9.94B
| $1.73M | ﹤0.01% |
11,015
+10,919
| +11,374% | +$1.94M |
|
5900
Greystone Housing Impact Investors LP
GHI
$139M
| $1.72M | ﹤0.01% |
168,286
+113,588
| +208% | +$1.37M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.